Ken Griffin Ice Cure Medical Ltd. Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 37,173 shares of ICCM stock, worth $26,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,173
Previous 52,524
29.23%
Holding current value
$26,392
Previous $52,000
28.85%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ICCM
# of Institutions
18Shares Held
294KCall Options Held
0Put Options Held
0-
Two Sigma Securities, LLC New York, NY50.2KShares$35,6220.01% of portfolio
-
Hrt Financial LP New York, NY46.7KShares$33,1550.0% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$28,7210.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC23.4KShares$16,5960.0% of portfolio
-
Ubs Group Ag21.6KShares$15,3650.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $26.2M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.